Scott Wagner - Mar 16, 2024 Form 4 Insider Report for GoodRx Holdings, Inc. (GDRX)

Role
Interim Chief Executive Officer
Signature
/s/ Gracye Cheng, Attorney-in-Fact for Scott Wagner
Stock symbol
GDRX
Transactions as of
Mar 16, 2024
Transactions value $
$0
Form type
4
Date filed
3/19/2024, 06:28 PM
Previous filing
Dec 11, 2023
Next filing
May 8, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding GDRX Class A Common Stock 183K Mar 16, 2024 By Wagner Family Trust F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GDRX Restricted Stock Unit Award $0 +565K $0.00 565K Mar 16, 2024 Class A Common Stock 565K Direct F2, F3
transaction GDRX Stock Option (Right to Buy) Award $0 +909K $0.00 909K Mar 16, 2024 Class A Common Stock 909K $6.91 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares held directly by the Wagner Family Trust (the "Trust"). The Reporting Person and his spouse serve as trustees of the Trust, and the Reporting Person, his spouse and other members of his immediate family are the sole beneficiaries of the Trust.
F2 Each restricted stock unit represents a contingent right to receive one share of Class A common stock.
F3 The restricted stock unit award will vest in approximately equal monthly installments over eight months beginning on May 8, 2024, subject to the Reporting Person's continued employment through the applicable vesting dates.
F4 The option will vest and become exercisable in approximately equal monthly installments over eight months beginning on May 8, 2024, subject to the Reporting Person's continued employment through the applicable vesting dates.

Remarks:

Interim Chief Executive Officer